CymitQuimica logo

CAS 161552-03-0

:

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
  • Cyclo(-Arg-Gly-Asp-D-Phe-Lys)

    CAS:
    An RGD tumor-targeting peptide, which binds to αvβ3 receptors. c(RGDfK) can be easily conjugated to fluorophore tags, chelators, or carriers. Palecek et al. converted the ε-amino group into the azide by diazo transfer allowing further functionalization by click chemistry. Mercapto groups can be introduced via acylation of c(RGDfK) with S-acetylthioacetic acid (SATA).
    Formula:C27H41N9O7
    Purity:98.0%
    Color and Shape:White
    Molecular weight:603.68

    Ref: 01-4069635

    1mg
    95.00€
    5mg
    365.00€
  • Cyclo(RGDfK)

    CAS:
    Formula:C27H41N9O7
    Purity:98%
    Color and Shape:Solid
    Molecular weight:603.6705

    Ref: IN-DA00AOJO

    10mg
    176.00€
    25mg
    291.00€
    50mg
    656.00€
    100mg
    To inquire
    250mg
    To inquire
  • Cyclo(-RGDfK)

    CAS:
    Cyclo(-RGDfK)
    Purity:≥95%
    Molecular weight:603.67g/mol

    Ref: 54-BUP08387

    5mg
    153.00€
    10mg
    254.00€
    25mg
    402.00€
    50mg
    550.00€
    100mg
    770.00€
    500mg
    1,246.00€
  • Cyclo(-RGDfK)

    CAS:
    <p>Cyclo(-RGDfK) is a selective and potent inhibitor of integrin αvβ3 with an IC50 value of 0.94 nM.Cost-effective and quality-assured.</p>
    Formula:C27H41N9O7
    Purity:95.29% - >99.99%
    Color and Shape:Solid
    Molecular weight:603.67
  • Cyclo(Arg-Gly-Asp-D-Phe-Lys)

    CAS:
    <p>Cyclo(Arg-Gly-Asp-D-Phe-Lys) is a small molecule drug that binds to the integrin receptor and blocks the growth of solid tumours. It has been shown to inhibit angiogenesis, especially in choroidal neovascularization in mice. Cyclo(Arg-Gly-Asp-D-Phe-Lys) is a cyclic peptide with biological properties that are similar to those of the natural amino acids found in protein. This drug has been shown to be safe for use in humans and animals, with no observed toxicity or side effects.</p>
    Formula:C27H41N9O7
    Purity:Min. 95%
    Molecular weight:603.68 g/mol

    Ref: 3D-PCI-3661-PI

    1mg
    135.00€
    5mg
    296.00€
    25mg
    931.00€
  • Cyclo(Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate

    CAS:
    <p>Cyclo(Arg-Gly-Asp-D-Phe-Lys) trifluoroacetate is a cyclic peptide, which functions as an integrin receptor antagonist. It is synthesized through solid-phase peptide synthesis, utilizing a sequence based on known integrin-binding motifs. The cyclic structure confers greater stability and binding affinity compared to linear counterparts.</p>
    Formula:C27H41N9O7•(C2HF3O2)x
    Purity:Min. 95%

    Ref: 3D-BC183585

    1g
    1,627.00€
    50mg
    341.00€
    100mg
    486.00€
    250mg
    806.00€
    500mg
    1,085.00€
  • Cyclo (-RGDfK) Trifluoroacetic Acid Salt

    Controlled Product
    CAS:
    <p>Applications Cyclo (-RGDfK) Trifluoroacetic Acid Salt is a potent inhibitor of αvβ3 integrin. Used in tumor therapy due to the targeting of the VEGFR2 gene by sRNA.<br>References Liu, L. et al.: Int. J. Nanomed., 9, 3509 (2014);<br></p>
    Formula:C27H41N9O7•x(C2HF3O2)
    Color and Shape:Neat
    Molecular weight:603.67 + x(114.02)

    Ref: TR-C989895

    5mg
    273.00€
    25mg
    827.00€
    100mg
    2,191.00€
  • Cyclo(Arg-Gly-Asp-D-Phe-Lys)

    CAS:
    <p>Cyclo(Arg-Gly-Asp-D-Phe-Lys) is a synthetic peptide that binds to the integrin receptor on pancreatic cancer cells. It has been shown to be an effective diagnostic tool for pancreatic cancer and other cancers, such as prostate, breast, and lung. Cyclo(Arg-Gly-Asp-D-Phe-Lys) selectively binds to cells with high levels of integrin receptors by using "a heterofunctional approach." This technique is used in the synthesis of peptides because it increases the stability of peptides. Cyclo(Arg-Gly-Asp-D-Phe-Lys) can be used for diagnosis or therapeutic purposes.</p>
    Formula:C27H41N9O7
    Purity:Min. 95%
    Molecular weight:603.68 g/mol

    Ref: 3D-PCI-3919-PI

    1mg
    Discontinued
    5mg
    Discontinued
    25mg
    Discontinued
    Discontinued product